Covered recipient · General Payments record
SVETLANA BABENKO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$685.20
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.58 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $128.77 | 7 |
| Amgen Inc. | $65.23 | 4 |
| GlaxoSmithKline, LLC. | $30.67 | 2 |
| Insulet Corporation | $21.57 | 1 |
| Lundbeck LLC | $17.07 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.00 | 1 |
| Acerta Pharma LLC | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.55 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498862 | CMS |
| Amgen Inc. | $16.74 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498864 | CMS |
| Amgen Inc. | $14.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117194682 | CMS |
| Amgen Inc. | $18.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117194680 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.27 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105833359 | CMS |
| GlaxoSmithKline, LLC. | $15.79 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116395564 | CMS |
| GlaxoSmithKline, LLC. | $14.88 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116605922 | CMS |
| Insulet Corporation | $21.57 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116812017 | CMS |
| Lundbeck LLC | $17.07 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145990251 | CMS |
| Novo Nordisk Inc | $18.02 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100430883 | CMS |
| Novo Nordisk Inc | $17.10 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100341516 | CMS |
| Novo Nordisk Inc | $16.87 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100639042 | CMS |
| Novo Nordisk Inc | $21.02 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100389741 | CMS |
| Novo Nordisk Inc | $17.14 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100261665 | CMS |
| Novo Nordisk Inc | $20.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100433633 | CMS |
| Novo Nordisk Inc | $17.82 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100277628 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.00 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119019416 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.